Survival after transfusion as assessed in a large multistate US cohort

Transfusion

Volumn 44, Issue 3, 2004, Pages 386-390

  Kleinman, Steven ^a   Marshall, Deborah ^b   AuBuchon, James ^b   Patton, Mary ^b  

^a Kleinman Biomedical Research   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL PRACTICE; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MANAGED CARE; MORTALITY; RISK REDUCTION; SURVIVAL RATE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INFANT; MIDDLE AGED; MODELS, STATISTICAL; RISK REDUCTION BEHAVIOR; SURVIVAL ANALYSIS; UNITED STATES;

EID: 1642385238     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2003.00660.x     Document Type: Article

References (14)

1. Menozzi D, Udulutch T, Llosa AE, Galel SA. HCV lookback in the United States: effectiveness of an extended lookback program. Transfusion 2000;40:1393-8.
2. Ward JW, Bush TJ, Perkins HA, et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med 1989;321:947-52.
3. Marshall DA, Kleinman SH, Wong JB, et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sanguinis 2004;86:28-40.
4. Vamvakas EC, Taswell HF. Long-term survival after blood transfusion. Transfusion 1994;34:471-7.
5. Vamvakas EC, Moore SB. Length of survival after perioperative transfusion. Transfus Med 1997;7:115-21.
6. Whyte GS. The transfused population of Canterbury, New Zealand, and its mortality. Vox Sang 1988;54:65-70.
7. Tynell E, Norda R, Shanwell A, Bjorkman A. Long-term survival in transfusion recipients in Sweden, 1993. Transfusion 2001;41:251-5.
8. Vamvakas EC, Goldstein R. Four-year survival of transfusion recipients identified by hepatitis C lookback. Transfusion 2002;42:691-7.
9. Wells AW, Chapman CE, Stainsby D, Wallis JP. Long term survival after transfusion in the north of England: a population based study (abstract). Vox Sang 2002;83(Suppl 2):219.
10. Titlestad K, Georgsen J. Proportion of blood components transfused to patients alive after a defined period (abstract). Vox Sang 2002;83 (Suppl 2):220.
11. Vamvakas EC. Long-term survival of transfusion recipients in Sweden, 1993 (letter). Transfusion 2001;41:1173-6.
12. Vamvakas EC. Ten-year survival of transfusion recipients identified by hepatitis C lookback (letter). Transfusion 2003;43:418-9.
13. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts: blood transfusion. N Engl J Med 1999;340:438-47.
14. Mathoulin-Pelissier S, Salmi LR, Verret C, Demoures B. Blood transfusion in a random sample of hospitals in France. Transfusion 2000;40:1140-6.